Panacea Biotec Share Price

  • 133.990.13 (0.10%)
  • Volume: 1,15,110
  • Closed
  • Last Updated On: 28 Jun, 2024, 03:57 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Panacea Biotec Share Pr...

  • 133.990.13 (0.10%)
  • Volume: 1,15,110
Advertisment

Panacea Biotec share price insights

View All

  • Company's annual revenue growth of 14.34% outperformed its 3 year CAGR of -2.66%. (Source: Consolidated Financials)

  • Stock gave a 3 year return of -63.6% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 26.75% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

  • Stock generated -63.6% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

  • Panacea Biotec Ltd. share price moved up by 0.10% from its previous close of Rs 133.86. Panacea Biotec Ltd. stock last traded price is 133.99

    Share PriceValue
    Today/Current/Last133.99
    Previous Day133.86134.55

InsightsPanacea Biotec

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		-885.46
    EPS - TTM
    (₹)    		-0.15
    MCap
    (₹ Cr.)    		832.34
    Sectoral MCap Rank
    		74
    PB Ratio
    (x)    		0.98
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		1.00
    Beta

    Beta

    1 Month2.85
    3 Months1.48
    6 Months1.57
    1 Year1.39
    3 Years1.66

    		2.85
    VWAP
    (₹)    		135.25
    52W H/L
    (₹)
    202.50 / 112.35

    Panacea Biotec Share Price Returns

    1 Day0.1%
    1 Week1.0%
    1 Month-1.04%
    3 Months10.23%
    1 Year6.0%
    3 Years-64.47%
    5 Years-14.55%

    ET Stock ScreenersTop Score Companies

    Check whether Panacea Biotec belongs to analysts' top-rated companies list?

    View Stock Screeners

    Panacea Biotec News & Analysis

    View all Panacea Biotec Share News & Announcements

    Panacea Biotec Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Panacea Biotec Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Panacea Biotec Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 14.34% outperformed its 3 year CAGR of -2.66%. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 26.75% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income147.27156.18146.25135.27143.99
      Total Income Growth (%)-5.706.798.12-6.0611.50
      Total Expenses148.57156.98153.12121.24124.73
      Total Expenses Growth (%)-5.362.5226.29-2.8056.85
      EBIT-1.30-0.80-6.8714.0319.26
      EBIT Growth (%)---148.97-27.15-61.19
      Profit after Tax (PAT)-1.43-2.20-8.2910.98-12.68
      PAT Growth (%)---175.50--165.46
      EBIT Margin (%)-0.88-0.51-4.7010.3713.38
      Net Profit Margin (%)-0.97-1.41-5.678.12-8.81
      Basic EPS (₹)-0.23-0.37-1.351.79-2.07
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income96.7698.2896.7292.7585.29
      Total Income Growth (%)-1.551.614.288.754.42
      Total Expenses94.7593.8089.9788.0077.49
      Total Expenses Growth (%)1.014.262.2413.5617.84
      EBIT2.014.486.754.757.80
      EBIT Growth (%)-55.13-33.6342.11-39.10-51.01
      Profit after Tax (PAT)-1.370.433.201.29-19.69
      PAT Growth (%)-418.60-86.56148.06--248.72
      EBIT Margin (%)2.084.566.985.129.15
      Net Profit Margin (%)-1.420.443.311.39-23.09
      Basic EPS (₹)-0.220.070.520.21-3.21
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue584.97511.61672.20634.78573.75
      Total Revenue Growth (%)14.34-23.895.8910.6424.41
      Total Expenses619.52601.47899.60779.11729.90
      Total Expenses Growth (%)3.00-33.1415.476.74-2.25
      Profit after Tax (PAT)-1.17-33.241,077.89-147.70-194.27
      PAT Growth (%)--103.08---614.93
      Operating Profit Margin (%)-5.53-18.57-7.046.563.27
      Net Profit Margin (%)-0.20-7.22163.01-23.63-35.70
      Basic EPS (₹)-0.19-5.43175.98-24.11-31.72
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue384.51291.50248.07364.30188.96
      Total Revenue Growth (%)31.9117.51-31.9192.7989.46
      Total Expenses380.30354.25341.65377.16252.49
      Total Expenses Growth (%)7.353.69-9.4149.38-33.65
      Profit after Tax (PAT)3.55-87.54-93.58-14.44-153.07
      PAT Growth (%)-----676.10
      Operating Profit Margin (%)5.00-20.49-36.74-1.55-36.85
      Net Profit Margin (%)0.98-34.05-39.73-4.20-96.82
      Basic EPS (₹)0.58-14.29-15.28-2.35-24.99

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets1,240.681,271.171,782.511,178.821,390.30
      Total Assets Growth (%)-2.40-28.6951.21-15.211.07
      Total Liabilities402.45426.07932.551,407.061,191.65
      Total Liabilities Growth (%)-5.54-54.31-33.7218.0817.11
      Total Equity838.23818.46845.81-253.35173.96
      Total Equity Growth (%)2.42-3.23--245.64-48.50
      Current Ratio (x)1.571.711.301.201.50
      Total Debt to Equity (x)0.020.020.04-2.923.47
      Contingent Liabilities0.00644.43373.48413.45368.66
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets753.64723.90761.83791.571,138.49
      Total Assets Growth (%)4.11-4.98-3.76-30.47-21.05
      Total Liabilities424.49393.27342.59279.95242.86
      Total Liabilities Growth (%)7.9414.7922.3815.27-76.03
      Total Equity329.15304.00393.44486.51870.94
      Total Equity Growth (%)8.27-22.73-19.13-44.14113.03
      Current Ratio (x)0.740.811.171.463.60
      Total Debt to Equity (x)0.380.320.200.120.07
      Contingent Liabilities0.00643.19372.80411.92368.16

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities-0.10-422.45-108.44106.76-30.47
      Net Cash used in Investing Activities10.23430.331,282.57-47.68-34.76
      Net Cash flow from Financing Activities-2.81-18.37-1,175.85-47.1190.74
      Net Cash Flow7.32-10.50-1.7311.9825.51
      Closing Cash & Cash Equivalent47.1739.8550.3552.1940.22
      Closing Cash & Cash Equivalent Growth (%)18.36-20.85-3.5329.78178.02
      Total Debt/ CFO (x)-209.90-0.04-0.286.85-20.14
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities37.27-10.74-52.6938.27-82.86
      Net Cash used in Investing Activities-51.012.4139.54-37.32-18.52
      Net Cash flow from Financing Activities12.829.019.83-7.20109.39
      Net Cash Flow-0.920.67-3.32-6.268.02
      Closing Cash & Cash Equivalent5.096.015.338.6614.92
      Closing Cash & Cash Equivalent Growth (%)-15.2512.64-38.40-41.96200.83
      Total Debt/ CFO (x)3.35-9.07-1.521.53-0.74

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)-0.13-4.04126.990.00-109.75
      Return on Capital Employed (%)-3.32-9.09-4.755.441.90
      Return on Assets (%)-0.09-2.6160.47-12.52-13.97
      Interest Coverage Ratio (x)1.60-10.43-0.020.220.10
      Asset Turnover Ratio (x)0.450.300.2453.0039.13
      Price to Earnings (x)-666.67-20.000.84-7.36-3.45
      Price to Book (x)0.880.811.07-4.343.79
      EV/EBITDA (x)108.23-9.81-122.8619.4319.57
      EBITDA Margin (%)1.02-10.06-0.4313.8611.22
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)1.07-28.79-23.78-2.96-17.57
      Return on Capital Employed (%)3.56-11.18-16.79-0.90-6.01
      Return on Assets (%)0.47-12.09-12.28-1.82-13.44
      Interest Coverage Ratio (x)2.84-2.80-8.53-0.71-11.06
      Asset Turnover Ratio (x)0.490.350.3043.4013.88
      Price to Earnings (x)212.77-7.58-9.71-75.76-4.38
      Price to Book (x)2.262.182.312.230.77
      EV/EBITDA (x)21.47-25.64-15.8049.90-21.50
      EBITDA Margin (%)10.86-10.96-25.526.18-19.83

    Financial InsightsPanacea Biotec

    • Income (P&L)

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 14.34% outperformed its 3 year CAGR of -2.66%. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 26.75% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Panacea Biotec Peer Comparison

    • Panacea Biotec Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -63.6% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated -63.6% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of -63.6% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated -63.6% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Panacea Biotec-885.460.99-0.13-3.32-0.09-2.66-5.53-0.26-0.191.570.02-209.90
          Syncom Form46.384.078.7812.896.253.1714.599.610.342.580.25-12.17
          Bliss GVS Pharma14.181.077.8014.516.2110.0719.8610.597.235.080.090.58
          Bajaj Healthcare-10.993.31-30.1016.37-10.95-10.0212.11-17.69-30.361.161.193.60
          Jagsonpal Pharm39.654.7511.9815.5010.344.2214.7010.768.4910.420.000.00
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Ind-Swift Labs
          • Albert David
          • Nectar Lifesc
          • Medicamen Bio
          • Kilitch Drug

          Choose from Stocks

            See All Parameters

          Peers InsightsPanacea Biotec

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of -63.6% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated -63.6% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Panacea Biotec Shareholding Pattern

          • QOQ Change

          • Total Shareholdings

          • Loading...
            Showing Panacea Biotec Shareholding as on 31 Mar 2024
            Category31 Mar 202431 Dec 202330 Sep 202330 Jun 2023
            Promoters73.5973.5973.5973.59
            Pledge0.000.000.000.00
            FII0.270.260.260.22
            DII0.840.690.570.54
            Mutual Funds0.000.000.000.00
            Others25.2925.4525.5825.64
          • Showing Shareholding as on 31 Mar 2024
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters4,50,73,86673.59 %0.00
            Pledge00.00 %0.00
            FII1,68,0640.27 %0.01
            DII5,11,7160.84 %0.15
            MF1430.00 %0.00
            Others1,54,97,10025.29 %-0.15

          MF Ownership

          MF Ownership as on 31 May 2024

          View all Mutual Fund Schemes

          Top Searches:

          Panacea Biotec News Panacea Biotec Quarterly Results Panacea Biotec Dividend Panacea Biotec Q1 ResultsPanacea Biotec Q2 ResultsPanacea Biotec Q3 ResultsPanacea Biotec Q4 Results

          Corporate Actions

          • Panacea Biotec Board Meeting/AGM

          • Panacea Biotec Dividends

          • Others
          • Meeting DateAnnounced onPurposeDetails
            May 30, 2024May 13, 2024Board MeetingAudited Results
            Feb 13, 2024Jan 30, 2024Board MeetingQuarterly Results
            Nov 10, 2023Oct 23, 2023Board MeetingQuarterly Results
            Sep 29, 2023Aug 14, 2023AGMA.G.M.
            Aug 12, 2023Jul 31, 2023Board MeetingQuarterly Results
          • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
            Final 75%0.75Sep 19, 2011May 13, 2011
            Final 25%0.25Sep 16, 2010May 07, 2010
            Final 100%1.0Sep 19, 2008Jun 27, 2008
            Final 100%1.0Sep 21, 2007Jun 14, 2007
            Final 100%1.0Sep 22, 2006May 23, 2006
          • All TypesEx-DateRecord DateAnnounced onDetails
            SplitsFeb 03, 2003Feb 11, 2003Oct 26, 2002Split: Old FV10.0| New FV:1.0

          About Panacea Biotec

          Panacea Biotec Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 820.70 Crore) operating in Pharmaceuticals sector. Panacea Biotec Ltd. key Products/Revenue Segments include Vaccines, Pharmaceutical Preparations, Scrap and Export Incentives for the year ending 31-Mar-2023. Show More

          • Executives

          • Auditors

          • RJ

            Rajesh Jain

            Chairman & Managing Director
            SJ

            Sandeep Jain

            Joint Managing Director
            AJ

            Ankesh Jain

            Whole Time Director
            BS

            Bhupinder Singh

            Non Executive Director
            Show More
          • Walker Chandiok & Co. LLP

          Industry

          Pharma - Indian

          Key Indices Listed on

          BSE SmallCap, BSE Healthcare, BSE AllCap, + 1 more

          Address

          Ambala-Chandigarh Highway,Lalru, Punjab - 140501

          Contact

          [email protected]

          http://www.panaceabiotec.com

          More Details

          FAQs about Panacea Biotec share

          • 1. What's Panacea Biotec share price today and what are Panacea Biotec share returns ?
            Panacea Biotec share price was Rs 133.99 as on 28 Jun, 2024, 03:57 PM IST. Panacea Biotec share price was up by 0.10% based on previous share price of Rs. 138.68. In last 1 Month, Panacea Biotec share price moved down by 1.04%.
          • 2. Who owns Panacea Biotec?
            Following are the key changes to Panacea Biotec shareholding:
            • Promoter holding has not changed in last 9 months and holds 73.59 stake as on 31 Mar 2024
            • Domestic Institutional Investors holding has gone up from 0.54 (30 Jun 2023) to 0.84 (31 Mar 2024)
            • Foreign Institutional Investors holding has gone up from 0.22 (30 Jun 2023) to 0.27 (31 Mar 2024)
            • Other investor holding have gone down from 25.64 (30 Jun 2023) to 25.29 (31 Mar 2024)
          • 3. What's the market capitalization of Panacea Biotec?
            Within the Pharmaceuticals sector, Panacea Biotec stock has a market cap rank of 74. Panacea Biotec has a market cap of Rs 832.34 Cr.
          • 4. What is Panacea Biotec's 52 week high / low?
            52 Week high of Panacea Biotec share is Rs 202.50 while 52 week low is Rs 112.35
          • 5. Who's the chairman of Panacea Biotec?
            Rajesh Jain is the Chairman & Managing Director of Panacea Biotec
          • 6. Who are the peers for Panacea Biotec in Pharmaceuticals sector?
            Top 10 Peers for Panacea Biotec are Jagsonpal Pharmaceuticals Ltd., Bajaj Healthcare Ltd., Albert David Ltd., Ind-Swift Laboratories Ltd., Nectar Lifesciences Ltd., Bliss GVS Pharma Ltd., Medicamen Biotech Ltd., Kilitch Drugs(I) Ltd., Wanbury Ltd. and Syncom Formulation (India) Ltd.
          • 7. What are the returns for Panacea Biotec share?
            Return Performance of Panacea Biotec Shares:
            • 1 Week: Panacea Biotec share price moved up by 1.00%
            • 1 Month: Panacea Biotec share price moved down by 1.04%
            • 3 Month: Panacea Biotec share price moved up by 10.23%
            • 6 Month: Panacea Biotec share price moved down by 20.43%
          • 8. What is the PE & PB ratio of Panacea Biotec?
            The PE ratio of Panacea Biotec stands at -872.24, while the PB ratio is 0.98.
          • 9. How can I quickly analyze Panacea Biotec stock?
            Panacea Biotec share can be quickly analyzed on following metrics:
            • Stock's PE is -885.46
            • Price to Book Ratio of 0.98
          • 10. What are the Panacea Biotec quarterly results?
            On Consoldiated basis, Panacea Biotec reported a total income and loss of Rs 147.27 Cr and Rs -1.43 respectively for quarter ending 2024-03-31. Total Income and loss for the year ending 2024-03-31 was Rs 584.97 Cr and Rs -1.17 Cr.
          • 11. What dividend is Panacea Biotec giving?
            Panacea Biotec Ltd. announced an equity dividend of 75% on a face value of 1.0 amounting to Rs 0.75 per share on 13 May 2011. The ex dividend date was 19 Sep 2011.
          • 12. What is the CAGR of Panacea Biotec?
            The CAGR of Panacea Biotec is -2.74.

          Trending in Markets

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Panacea Biotec Share Price
          The Economic Times